Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review.

Shields GE, Buck D, Elvidge J, Hayhurst KP, Davies LM.

Int J Technol Assess Health Care. 2019;35(4):317-326. doi: 10.1017/S0266462319000448. Epub 2019 Jul 22.

2.

The COMMAND trial of cognitive therapy for harmful compliance with command hallucinations (CTCH): a qualitative study of acceptability and tolerability in the UK.

Birchwood M, Mohan L, Meaden A, Tarrier N, Lewis S, Wykes T, Davies LM, Dunn G, Peters E, Michail M.

BMJ Open. 2018 Jun 15;8(6):e021657. doi: 10.1136/bmjopen-2018-021657.

3.

Long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity: cluster-randomised trial.

Camacho EM, Davies LM, Hann M, Small N, Bower P, Chew-Graham C, Baguely C, Gask L, Dickens CM, Lovell K, Waheed W, Gibbons CJ, Coventry P.

Br J Psychiatry. 2018 Aug;213(2):456-463. doi: 10.1192/bjp.2018.70. Epub 2018 May 15.

4.

Cost-effectiveness of cardiac rehabilitation: a systematic review.

Shields GE, Wells A, Doherty P, Heagerty A, Buck D, Davies LM.

Heart. 2018 Sep;104(17):1403-1410. doi: 10.1136/heartjnl-2017-312809. Epub 2018 Apr 13.

5.

Unmet supportive care needs, health status and minimum costs in survivors of malignant melanoma.

Davies LM, Hayhurst KP, Lorigan P, Molassiotis A.

Eur J Cancer Care (Engl). 2018 Mar;27(2):e12811. doi: 10.1111/ecc.12811. Epub 2018 Jan 9.

PMID:
29315912
6.

A (five-)level playing field for mental health conditions?: exploratory analysis of EQ-5D-5L-derived utility values.

Camacho EM, Shields G, Lovell K, Coventry PA, Morrison AP, Davies LM.

Qual Life Res. 2018 Mar;27(3):717-724. doi: 10.1007/s11136-017-1768-1. Epub 2017 Dec 16.

7.

A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European Union.

Shields GE, Elvidge J, Davies LM.

BMJ Open. 2017 Jun 10;7(6):e014847. doi: 10.1136/bmjopen-2016-014847. Review.

8.

Cost-effectiveness of structured group psychoeducation versus unstructured group support for bipolar disorder: Results from a multi-centre pragmatic randomised controlled trial.

Camacho EM, Ntais D, Jones S, Riste L, Morriss R, Lobban F, Davies LM.

J Affect Disord. 2017 Mar 15;211:27-36. doi: 10.1016/j.jad.2017.01.005. Epub 2017 Jan 4.

PMID:
28086146
9.

Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.

Camacho EM, Ntais D, Coventry P, Bower P, Lovell K, Chew-Graham C, Baguley C, Gask L, Dickens C, Davies LM.

BMJ Open. 2016 Oct 7;6(10):e012514. doi: 10.1136/bmjopen-2016-012514.

10.

Spontaneous onset of labor, not route of delivery, is associated with prolonged length of stay in babies with gastroschisis.

Yang EY, Davies LM, Buchanan P, Kling C, Banyard DA, Ramones T.

J Pediatr Surg. 2014 Dec;49(12):1776-81. doi: 10.1016/j.jpedsurg.2014.09.021. Epub 2014 Oct 12.

PMID:
25487482
11.

Psoriasis treatment and management - a systematic review of full economic evaluations.

Hamilton MP, Ntais D, Griffiths CE, Davies LM; Identification and Management of Psoriasis-Associated ComorbidiTy (IMPACT) Team.

Br J Dermatol. 2015 Mar;172(3):574-83. doi: 10.1111/bjd.13486. Epub 2015 Feb 11. Review.

PMID:
25324036
12.

Motor neurone disease.

Nageshwaran S, Davies LM, Rafi I, Radunović A.

BMJ. 2014 Jul 9;349:g4052. doi: 10.1136/bmj.g4052. No abstract available.

PMID:
25008100
13.

Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial.

Morrison AP, Turkington D, Pyle M, Spencer H, Brabban A, Dunn G, Christodoulides T, Dudley R, Chapman N, Callcott P, Grace T, Lumley V, Drage L, Tully S, Irving K, Cummings A, Byrne R, Davies LM, Hutton P.

Lancet. 2014 Apr 19;383(9926):1395-403. doi: 10.1016/S0140-6736(13)62246-1. Epub 2014 Feb 6.

PMID:
24508320
14.

An exploratory randomized controlled study of a healthy living intervention in early intervention services for psychosis: the INTERvention to encourage ACTivity, improve diet, and reduce weight gain (INTERACT) study.

Lovell K, Wearden A, Bradshaw T, Tomenson B, Pedley R, Davies LM, Husain N, Woodham A, Escott D, Swarbrick CM, Femi-Ajao O, Warburton J, Marshall M.

J Clin Psychiatry. 2014 May;75(5):498-505. doi: 10.4088/JCP.13m08503.

PMID:
24500028
15.

How to recognise and treat peripheral nervous system vasculitis.

Marsh EA, Davies LM, Llewelyn JG.

Pract Neurol. 2013 Dec;13(6):408-11. doi: 10.1136/practneurol-2012-000464. Epub 2013 May 10. Review.

PMID:
23667156
16.

BMP4 sufficiency to induce choroid plexus epithelial fate from embryonic stem cell-derived neuroepithelial progenitors.

Watanabe M, Kang YJ, Davies LM, Meghpara S, Lau K, Chung CY, Kathiriya J, Hadjantonakis AK, Monuki ES.

J Neurosci. 2012 Nov 7;32(45):15934-45. doi: 10.1523/JNEUROSCI.3227-12.2012.

17.

Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.

Morrison AP, French P, Stewart SL, Birchwood M, Fowler D, Gumley AI, Jones PB, Bentall RP, Lewis SW, Murray GK, Patterson P, Brunet K, Conroy J, Parker S, Reilly T, Byrne R, Davies LM, Dunn G.

BMJ. 2012 Apr 5;344:e2233. doi: 10.1136/bmj.e2233.

18.

Valuing the economic benefits of complex interventions: when maximising health is not sufficient.

Payne K, McAllister M, Davies LM.

Health Econ. 2013 Mar;22(3):258-71. doi: 10.1002/hec.2795. Epub 2012 Feb 6.

PMID:
22308053
19.

Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics.

Morrison AP, Stewart SL, French P, Bentall RP, Birchwood M, Byrne R, Davies LM, Fowler D, Gumley AI, Jones PB, Lewis SW, Murray GK, Patterson P, Dunn G.

Early Interv Psychiatry. 2011 Feb;5(1):24-32. doi: 10.1111/j.1751-7893.2010.00254.x.

PMID:
21272272
20.

Interaction with caveolin-1 modulates vascular ATP-sensitive potassium (KATP) channel activity.

Davies LM, Purves GI, Barrett-Jolley R, Dart C.

J Physiol. 2010 Sep 1;588(Pt 17):3255-66. doi: 10.1113/jphysiol.2010.194779. Epub 2010 Jul 12.

21.

Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.

Rudland PS, Platt-Higgins AM, Davies LM, de Silva Rudland S, Wilson JB, Aladwani A, Winstanley JH, Barraclough DL, Barraclough R, West CR, Jones NJ.

Am J Pathol. 2010 Jun;176(6):2935-47. doi: 10.2353/ajpath.2010.090779. Epub 2010 Apr 2.

22.

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis.

Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Verstappen SM, Watson K, Symmons DP; British Society for Rheumatology Biologics Register Control Centre Consortium.

Qual Life Res. 2009 Nov;18(9):1195-205. doi: 10.1007/s11136-009-9539-2. Epub 2009 Sep 24.

23.

Development of a bioactive paper sensor for detection of neurotoxins using piezoelectric inkjet printing of sol-gel-derived bioinks.

Hossain SM, Luckham RE, Smith AM, Lebert JM, Davies LM, Pelton RH, Filipe CD, Brennan JD.

Anal Chem. 2009 Jul 1;81(13):5474-83. doi: 10.1021/ac900660p.

PMID:
19492815
24.

Exchange protein activated by cAMP (Epac) mediates cAMP-dependent but protein kinase A-insensitive modulation of vascular ATP-sensitive potassium channels.

Purves GI, Kamishima T, Davies LM, Quayle JM, Dart C.

J Physiol. 2009 Jul 15;587(Pt 14):3639-50. doi: 10.1113/jphysiol.2009.173534.

25.

Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.

Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Farragher TM, Verstappen SM, Hassell A, Symmons DP.

Value Health. 2009 Sep;12(6):1026-34. doi: 10.1111/j.1524-4733.2009.00565.x. Epub 2009 May 15.

26.

Science into policy: preparing for pandemic influenza.

Harper DR, Davies LM, Gadd EM, Costigan SC.

J Public Health (Oxf). 2008 Dec;30(4):373-4. doi: 10.1093/pubmed/fdn049. Epub 2008 Jul 4.

27.

Outcome measurement in clinical genetics services: a systematic review of validated measures.

Payne K, Nicholls S, McAllister M, Macleod R, Donnai D, Davies LM.

Value Health. 2008 May-Jun;11(3):497-508. doi: 10.1111/j.1524-4733.2007.00259.x. Review.

28.

The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review.

Harrison MJ, Davies LM, Bansback NJ, Ingram M, Anis AH, Symmons DP.

J Rheumatol. 2008 Apr;35(4):592-602. Epub 2008 Feb 15. Review.

PMID:
18278841
29.

A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine.

Davies LM, Barnes TR, Jones PB, Lewis S, Gaughran F, Hayhurst K, Markwick A, Lloyd H; CUTLASS Team.

Value Health. 2008 Jul-Aug;11(4):549-62. doi: 10.1111/j.1524-4733.2007.00280.x. Epub 2007 Dec 18.

30.

Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy.

Davies LM, Lewis S, Jones PB, Barnes TR, Gaughran F, Hayhurst K, Markwick A, Lloyd H; CUtLASS team.

Br J Psychiatry. 2007 Jul;191:14-22.

PMID:
17602120
31.

Angiotensin II-activated protein kinase C targets caveolae to inhibit aortic ATP-sensitive potassium channels.

Sampson LJ, Davies LM, Barrett-Jolley R, Standen NB, Dart C.

Cardiovasc Res. 2007 Oct 1;76(1):61-70. Epub 2007 May 24.

PMID:
17582389
32.

Outcome measures for clinical genetics services: a comparison of genetics healthcare professionals and patients' views.

Payne K, Nicholls SG, McAllister M, MacLeod R, Ellis I, Donnai D, Davies LM.

Health Policy. 2007 Nov;84(1):112-22. Epub 2007 May 7.

PMID:
17485130
33.

Array comparative genomic hybridization for diagnosis of developmental delay: an exploratory cost-consequences analysis.

Newman WG, Hamilton S, Ayres J, Sanghera N, Smith A, Gaunt L, Davies LM, Clayton-Smith J.

Clin Genet. 2007 Mar;71(3):254-9.

PMID:
17309648
34.

Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families.

McAllister M, Payne K, Nicholls S, MacLeod R, Donnai D, Davies LM.

J Genet Couns. 2007 Feb;16(1):71-83. Epub 2007 Feb 13.

PMID:
17295055
35.

Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?

Davies LM, Fargher EA, Tricker K, Dawes P, Scott DL, Symmons D.

Ann Rheum Dis. 2007 May;66(5):658-63. Epub 2006 Nov 23.

36.

The influence of hypothermia on outcome after intracerebral hemorrhage in rats.

MacLellan CL, Davies LM, Fingas MS, Colbourne F.

Stroke. 2006 May;37(5):1266-70. Epub 2006 Mar 30.

PMID:
16574928
37.
38.
39.

Costing day case anesthesia: obtaining accurate patient-based costs for adults and children.

Elliott RA, Davies LM, Payne K, Moore JK, Harper NJ.

Int J Technol Assess Health Care. 2004 Fall;20(4):552-61.

PMID:
15609809
40.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

41.

Estrogen increases proteasome activity in murine microglial cells.

Reed JL, Dimayuga FO, Davies LM, Keller JN, Bruce-Keller AJ.

Neurosci Lett. 2004 Aug 26;367(1):60-5.

PMID:
15308298
42.
43.

Atomic force microscopy of microfibrils in primary cell walls.

Davies LM, Harris PJ.

Planta. 2003 Jun;217(2):283-9. Epub 2003 Feb 11.

PMID:
12783336
44.

Which anaesthetic agents are cost-effective in day surgery? Literature review, national survey of practice and randomised controlled trial.

Elliott RA, Payne K, Moore JK, Davies LM, Harper NJ, St Leger AS, Moore EW, Thoms GM, Pollard BJ, McHugh GA, Bennett J, Lawrence G, Kerr J.

Health Technol Assess. 2002;6(30):1-264. Review. No abstract available.

45.

The value of the managed entry of new drugs: a case study of donepezil.

Payne K, Davies LM, Noyce PR, Weiss MC.

Int J Technol Assess Health Care. 2003 Winter;19(1):114-28.

PMID:
12701944
46.

Clinical and economic choices in anaesthesia for day surgery: a prospective randomised controlled trial.

Elliott RA, Payne K, Moore JK, Harper NJ, St Leger AS, Moore EW, Thoms GM, Pollard BJ, McHugh GA, Bennett J, Lawrence G, Kerr J, Davies LM.

Anaesthesia. 2003 May;58(5):412-21.

47.

The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review.

Berry E, Kelly S, Westwood ME, Davies LM, Gough MJ, Bamford JM, Meaney JF, Airey CM, Cullingworth J, Barbieri M, Jackson A, Smith MA.

Health Technol Assess. 2002;6(7):1-155. Review. No abstract available.

48.

How to undertake a clinically relevant systematic review in a rapidly evolving field. Magnetic resonance angiography.

Westwood ME, Kelly S, Berry E, Bamford JM, Gough MJ, Airey CM, Davies LM, Meaney JF, Cullingworth J, Smith MA.

Int J Technol Assess Health Care. 2002 Winter;18(1):24-32.

PMID:
11987439
50.

Use of magnetic resonance angiography to select candidates with recently symptomatic carotid stenosis for surgery: systematic review.

Westwood ME, Kelly S, Berry E, Bamford JM, Gough MJ, Airey CM, Meaney JF, Davies LM, Cullingworth J, Smith MA.

BMJ. 2002 Jan 26;324(7331):198. Review.

Supplemental Content

Loading ...
Support Center